Format

Send to

Choose Destination
Physiol Res. 2003;52(1):61-6.

Serum ghrelin levels in obese patients: the relationship to serum leptin levels and soluble leptin receptors levels.

Author information

1
Third Department of Internal Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic. rosi@email.cz

Abstract

Ghrelin is a new endogenous ligand for the growth hormone secretagogue receptor. It activates the release of growth hormone from the pituitary and it also participates in the regulation of energy homeostasis. The aim of the study was to characterize changes in serum ghrelin levels in obese subjects and their relationship to the serum levels of leptin and soluble leptin receptor. Eight obese patients (6 women and 2 men) with body mass index (BMI) 40.3+/-13.4 kg.m(-2) and eight healthy controls (5 women and 3 men) with BMI 22.7+/-1.3 kg.m(-2) were examined. The ghrelin serum levels (165.0+/-58.1 vs. 343.37+/-81.96; p<0.001) and soluble leptin receptor serum levels (7.25+/-3.44 vs. 21.80+/-4.99; p<0.0001) were significantly lower in obese patients. The leptin serum levels (23.45+/-12.90 vs. 6.41+/-2.96; p<0.005) were significantly higher compared to the lean subject group. In both measured groups the levels of serum leptin significantly positively correlated with BMI. We proved a significantly lower serum ghrelin levels in the group of obese patients in comparison with the control group.

PMID:
12625808
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Institute of Physiology, Academy of Sciences of the Czech Republic, Prague
Loading ...
Support Center